Epygenix Therapeutics Announces FDA Acceptance of IND to …
https://www.prnewswire.com/news-releases/epygenix-therapeutics-announces-fda-acceptance-of-ind-to-initiate-a-clinical-trial-of-epx-100-to-treat-lennox-gastaut-syndrome-301364855.html
WEBAug 30, 2021 · Alex Yang, J.D., LLM, President and CEO of Mstone Partners and Chair of the Board at Epygenix Therapeutics also stated that "Epygenix is committed to provide …
DA: 1 PA: 39 MOZ Rank: 92